Top compounds associated with response to AAED1


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.033 0.6
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.062 0.2
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.049 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.04
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.1
mRNA tandutinib CTRPv2 pan-cancer AAC -0.027 0.5
mRNA tamatinib CTRPv2 pan-cancer AAC 0.034 0.4
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.057 0.1
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.15 0.0004
mRNA staurosporine CTRPv2 pan-cancer AAC 0.018 0.8
Download CSV